Ottawa Hospital Cancer Centre

Ottawa, Ontario ON K1H 8L6

2 studies enrolling now · 18 studies all time

What they study most

Adenoid Cystic Carcinoma, Advanced Breast Cancer, Advanced Gastric Cancer, Breast Cancer, Breast Cancer With Low to Intermediate HER2 Expression, Breast Neoplasms, Cancer, Cancer With A High Tumor Mutational Burden, Cancer, Advanced Solid Tumors, Carcinoma, Non-Small-Cell Lung, Clear Cell Renal Cell Carcinoma, Colon Cancer

Studies at this site

• International Registry for Men With Advanced Prostate Cancer (IRONMAN) — Recruiting now
• Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC) — Recruiting now
• A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer — Running, not enrolling
• A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors — Running, not enrolling
• Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma — Running, not enrolling
• Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03) — Running, not enrolling
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• A Study of LY2880070 in Participants With Advanced or Metastatic Cancer — Completed
• Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma — Completed
• A Study of SGN-ALPV in Advanced Solid Tumors — Stopped early
• Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer — Running, not enrolling
• A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies — Running, not enrolling
• A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies — Completed
• A Study of BBI503 in Adult Patients With Advanced Solid Tumors — Completed
• A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) — Completed
• Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3) — Completed
• A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer — Completed
• Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence — Completed